Literature DB >> 25182065

Comment on: Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study.

Jotam G Pasipanodya1, Shashikant Srivastava1, Tawanda Gumbo2.   

Abstract

Entities:  

Keywords:  Mycobacterium tuberculosis; pharmacodynamics; pharmacokinetics

Mesh：

Substances：

Year:  2014        PMID： 25182065     DOI： 10.1093/jac/dku345

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  2 in total

1.  Reply to "adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future".

Authors:  Ana Requena-Méndez; Geraint Davies; David A J Moore
Journal:  Antimicrob Agents Chemother       Date:  2015-04       Impact factor: 5.191

2.  Adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future.

Authors:  Marieke G G Sturkenboom; Onno W Akkerman; Mathieu S Bolhuis; Wiel C M de Lange; Tjip S van der Werf; Jan-Willem C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2015-04       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.